{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:31:18Z","timestamp":1766082678169,"version":"3.48.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012157","name":"Shanghai Key Discipline Construction Project","doi-asserted-by":"publisher","award":["STS-ZYX-2017012"],"award-info":[{"award-number":["STS-ZYX-2017012"]}],"id":[{"id":"10.13039\/501100012157","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.biopha.2020.110638","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T01:45:18Z","timestamp":1599615918000},"page":"110638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Inhibitory effect of simiao qingwen baidu decoction on epstein-barr virus EA, VCA expression and DNA replication in vitro"],"prefix":"10.1016","volume":"131","author":[{"given":"Yongbin","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiying","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2020.110638_bib0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.5114\/aoms.2013.37274","article-title":"Association of Epstein-Barr virus infection and breast carcinoma","volume":"9","author":"Khabaz","year":"2013","journal-title":"Archives med. Sci. AMS"},{"issue":"1","key":"10.1016\/j.biopha.2020.110638_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115836","article-title":"A large-scale seroprevalence of Epstein-Barr virus in Taiwan","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110638_bib0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12985-015-0441-y","article-title":"Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children","volume":"12","author":"Gao","year":"2015","journal-title":"Virol. J."},{"issue":"15","key":"10.1016\/j.biopha.2020.110638_bib0020","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1128\/JVI.00958-15","article-title":"Regulation of DNA damage signaling and cell death responses by epstein-barr virus latent membrane protein 1 (LMP1) and LMP2A in nasopharyngeal carcinoma cells","volume":"89","author":"Wasil","year":"2015","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110638_bib0025","doi-asserted-by":"crossref","DOI":"10.4322\/acr.2019.117","article-title":"Intraoral EBV-positive sporadic Burkitt lymphoma in an elderly patient with bilateral presentation","volume":"9","author":"Pedraza","year":"2019","journal-title":"Autops. Case Rep."},{"issue":"9","key":"10.1016\/j.biopha.2020.110638_bib0030","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2019-215361","article-title":"Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals","volume":"78","author":"Jog","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2020.110638_bib0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.celrep.2013.01.023","article-title":"Human complement receptor type 1\/CD35 is an Epstein-Barr Virus receptor","volume":"3","author":"Ogembo","year":"2013","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.biopha.2020.110638_bib0040","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1128\/JVI.02425-10","article-title":"The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus","volume":"85","author":"Dheekollu","year":"2011","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110638_bib0045","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/jmv.23911","article-title":"Sequence analysis of EBV immediate-early gene BZLF1 and BRLF1 in lymphomas","volume":"86","author":"Yang","year":"2014","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110638_bib0050","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1099\/jgv.0.000230","article-title":"Transcriptional activation of epstein-barr virus BRLF1 by USF1 and rta","volume":"96","author":"Hung","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110638_bib0055","first-page":"128","article-title":"Inhibition of the expression of Epstein Barr virus antigens in vitro by Chinese medicine compound \u201cDongxia wan\u201d","volume":"14","author":"Peichun","year":"2000","journal-title":"Chinese J. Exper. Clin. Virology"},{"issue":"5","key":"10.1016\/j.biopha.2020.110638_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/v11050450","article-title":"Inhibition of epstein-barr virus lytic reactivation by the atypical antipsychotic drug clozapine","volume":"11","author":"Anderson","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2020.110638_bib0065","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2020.110638_bib0070","first-page":"289","article-title":"Epstein-barr virus-specific humoral immune responses in health and disease","volume":"391","author":"Middeldorp","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110638_bib0075","first-page":"543","article-title":"Inhibition of Anti-EB Virus Liquor on EB virus antigen expression and its cytotoxicity","volume":"35","author":"Zongchao","year":"2004","journal-title":"Chinese Traditional Herbal Drugs."},{"key":"10.1016\/j.biopha.2020.110638_bib0080","unstructured":"Y.S.-q. LIU X iao-hong, Z HOU Ling, L I Li Comparative study on the inhibition of EB virus antigen expression by common andrographis herb extract versus aciclovir., Chin J Infect Chemother. 7(6) (2007) 445-447."},{"issue":"3","key":"10.1016\/j.biopha.2020.110638_bib0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/rmv.1780","article-title":"Switching of EBV cycles between latent and lytic states","volume":"24","author":"Murata","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.biopha.2020.110638_bib0090","first-page":"237","article-title":"Epstein-barr virus lytic cycle reactivation","volume":"391","author":"McKenzie","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"51","key":"10.1016\/j.biopha.2020.110638_bib0095","doi-asserted-by":"crossref","first-page":"35896","DOI":"10.1074\/jbc.M109.051581","article-title":"Crystal structure of epstein-barr virus DNA polymerase processivity factor BMRF1","volume":"284","author":"Murayama","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2020.110638_bib0100","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1128\/JVI.80.10.5078-5081.2006","article-title":"The Epstein-Barr virus BMRF1 gene is essential for lytic virus replication","volume":"80","author":"Neuhierl","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110638_bib0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1073\/pnas.1321800111","article-title":"Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription","volume":"111","author":"Chen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.biopha.2020.110638_bib0110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.coviro.2012.09.005","article-title":"EBNA1 and host factors in Epstein-Barr virus latent DNA replication","volume":"2","author":"Frappier","year":"2012","journal-title":"Curr. Opin. Virol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110638_bib0115","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/v4091537","article-title":"Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival","volume":"4","author":"Frappier","year":"2012","journal-title":"Viruses"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220308313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220308313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:28:50Z","timestamp":1766082530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220308313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":23,"alternative-id":["S0753332220308313"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110638","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effect of simiao qingwen baidu decoction on epstein-barr virus EA, VCA expression and DNA replication in vitro","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110638"}}